Revolutionary drug for schizophrenia wins US approval

Nature. 2024 Oct;634(8033):276-277. doi: 10.1038/d41586-024-03123-9.
No abstract available

Keywords: Drug discovery; Medical research; Psychiatric disorders; Schizophrenia.

Publication types

  • News

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • Antipsychotic Agents* / pharmacology
  • Antipsychotic Agents* / therapeutic use
  • Benzilates* / adverse effects
  • Benzilates* / pharmacology
  • Benzilates* / therapeutic use
  • Drug Approval*
  • Humans
  • Nortropanes* / adverse effects
  • Nortropanes* / pharmacology
  • Nortropanes* / therapeutic use
  • Schizophrenia* / drug therapy
  • Thiadiazoles* / adverse effects
  • Thiadiazoles* / pharmacology
  • Thiadiazoles* / therapeutic use
  • United States
  • United States Food and Drug Administration* / legislation & jurisprudence

Substances

  • Antipsychotic Agents
  • Xanomeline-Trospium
  • Benzilates
  • Nortropanes
  • Thiadiazoles